<?xml version="1.0" encoding="UTF-8"?>
<ref id="B103-pharmaceuticals-12-00157">
 <label>103.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ekins</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Mietchen</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Coffee</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Stratton</surname>
    <given-names>T.P.</given-names>
   </name>
   <name>
    <surname>Freundlich</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Freitas-Junior</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Muratov</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Siqueira-Neto</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Andrade</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Open drug discovery fore the Zika virus</article-title>
  <source>F1000Research</source>
  <year>2016</year>
  <volume>5</volume>
  <elocation-id>150</elocation-id>
  <pub-id pub-id-type="doi">10.12688/f1000research.8013.1</pub-id>
  <pub-id pub-id-type="pmid">27134728</pub-id>
 </element-citation>
</ref>
